IRIS
CAPECCHI, PIER LEOPOLDO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8136
EU - Europa 5907
AS - Asia 1076
OC - Oceania 13
SA - Sud America 11
Continente sconosciuto - Info sul continente non disponibili 7
AF - Africa 4
AN - ???statistics.table.value.continent.AN??? 1
Totale 15155
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8112
GB - Regno Unito 2350
CN - Cina 856
SE - Svezia 788
IT - Italia 703
UA - Ucraina 683
DE - Germania 454
FR - Francia 391
IE - Irlanda 261
VN - Vietnam 135
FI - Finlandia 92
BE - Belgio 73
ES - Italia 41
TR - Turchia 29
RU - Federazione Russa 26
CA - Canada 21
IN - India 21
TH - Thailandia 17
AU - Australia 11
IR - Iran 11
GR - Grecia 9
NL - Olanda 8
BR - Brasile 7
EU - Europa 7
PL - Polonia 4
CH - Svizzera 3
HR - Croazia 3
MK - Macedonia 3
BG - Bulgaria 2
IM - Isola di Man 2
NZ - Nuova Zelanda 2
RO - Romania 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
AM - Armenia 1
AT - Austria 1
BA - Bosnia-Erzegovina 1
CL - Cile 1
DK - Danimarca 1
EC - Ecuador 1
EG - Egitto 1
FK - Isole Falkland (Malvinas) 1
GS - Georgia del Sud e Isole Sandwich Australi 1
HK - Hong Kong 1
HU - Ungheria 1
ID - Indonesia 1
IL - Israele 1
JM - Giamaica 1
JP - Giappone 1
KZ - Kazakistan 1
MA - Marocco 1
MX - Messico 1
NG - Nigeria 1
NP - Nepal 1
PA - Panama 1
PE - Perù 1
PT - Portogallo 1
ZA - Sudafrica 1
Totale 15155
Salva come PNG Salva come JPEG
Città #
Southend 2237
Fairfield 1435
Chandler 710
Woodbridge 673
Ashburn 550
Jacksonville 549
Wilmington 535
Houston 528
Seattle 502
Cambridge 464
Ann Arbor 363
Menlo Park 358
Siena 326
Dublin 261
Princeton 244
Beijing 222
Nanjing 201
Dong Ket 135
Dearborn 108
San Diego 94
San Mateo 89
Brussels 73
Nanchang 73
Boardman 71
Shenyang 51
Málaga 41
Düsseldorf 34
Hebei 31
Tianjin 30
Changsha 26
Kunming 26
Izmir 25
Florence 24
Lancaster 24
Jiaxing 23
Norwalk 23
Jinan 22
Falls Church 21
London 21
Guangzhou 20
San Francisco 20
Hefei 18
Toronto 18
Fremont 15
Rome 14
Venezia 14
Zhengzhou 13
Redwood City 12
Mestre 11
Ningbo 11
Hangzhou 10
Changchun 9
Lanzhou 9
Chicago 8
Taizhou 8
Arezzo 7
Fuzhou 7
Milan 7
Sacramento 7
Aulla 6
Canberra 6
Paris 6
Phoenix 6
Auburn Hills 5
Turin 5
Zanjan 5
Bari 4
Modena 4
Philadelphia 4
Queens 4
San Giovanni Valdarno 4
Scandicci 4
São Paulo 4
Amsterdam 3
Anguillara Sabazia 3
Athens 3
Bologna 3
Campi Bisenzio 3
Grosseto 3
Monte San Savino 3
Ottawa 3
Parabiago 3
Perugia 3
Pisa 3
Prato 3
Redmond 3
Sydney 3
Warsaw 3
Wuhan 3
Xian 3
Zagreb 3
Auckland 2
Belgrade 2
Bratislava 2
Cagliari 2
Casaleone 2
Certaldo 2
Chengdu 2
Chongqing 2
Como 2
Totale 11600
Salva come PNG Salva come JPEG
Nome #
Systemic inflammation as a novel QT-prolonging risk factor in patients with torsades de pointes 250
Marked QTc Prolongation and Torsades de pointes in Patients with Chronic Inflammatory Arthritis 224
Searching Novel Therapeutic Targets for Scleroderma: P2X7-Receptor Is Up-regulated and Promotes a Fibrogenic Phenotype in Systemic Sclerosis Fibroblasts 217
Proton pump inhibitors and serum magnesium levels in patients with Torsades de Pointes 204
Arrhythmogenicity of Anti-Ro/SSA antibodies in patients with torsades de pointes 199
Adenosine A2A receptor activation stimulates collagen production in sclerodermic dermal fibroblasts either directly and through a cross-talk with the cannabinoid system 189
Adherence to antithrombotic therapy guidelines improves mortality among elderly patients with atrial fibrillation: insights from the REPOSI study 188
Association between high sensitivity C-reactive protein, heart rate variability and corrected QT interval in patients with chronic inflammatory arthritis. 187
Torsades de Pointes in patients with polymyalgia rheumatica 186
The purinergic P2×7 receptor is expressed on monocytes in Behçet's disease and is modulated by TNF-α 181
Gender-differences in disease distribution and outcome in hospitalized elderly: Data from the REPOSI study 180
Antiarrhythmic potential of anti-cytokine therapy in rheumatoid arthritis: Tocilizumab reduces QTc interval by controlling systemic inflammation. 175
Adherence to antibiotic treatment guidelines and outcomes in the hospitalized elderly with different types of pneumonia 171
Polyneuropathy with demyelinating changes in Churg–Strauss syndrome: an unusual association 168
Spotlight on sirukumab for the treatment of rheumatoid arthritis: The evidence to date 167
Levels of circulating CXCR4-positive cells are decreased and negatively correlated with risk factors in cardiac transplant recipients 163
Induction of autoimmune response to the extracellular loop of the HERG channel pore induces QTc prolongation in guinea-pigs 162
Prevalence and Determinants of the Use of Lipid-Lowering Agents in a Population of Older Hospitalized Patients: the Findings from the REPOSI (REgistro POliterapie Società Italiana di Medicina Interna) Study 160
Adenosine receptors expression in cardiac fibroblasts of patients with left ventricular dysfunction due to valvular disease 155
Pleuroparenchymal fibroelastosis (PPFE) associated with giant cell arteritis: A coincidence or a novel phenotype? 152
Peripheral biomarkers' panel for severe COVID-19 patients 152
Systemic Inflammation Rapidly Induces Reversible Atrial Electrical Remodeling: The Role of Interleukin-6–Mediated Changes in Connexin Expression 151
Antirheumatic agents in covid-19: is IL-6 the right target? 151
Synthetic cannabinoid ajulemic acid exerts potent antifibrotic effects in experimental models of systemic sclerosis 148
Connective tissue diseases and cardiac rhythm disorders: an overview. 146
Anti-Ro/SSA-associated corrected QT interval prolongation in adults: the role of antibody level and specificity. 143
Risk factors for hospital readmission of elderly patients 143
Statins and the joint: multiple targets for a global protection? 142
Isolated atrioventricular block of unknown origin in the adult and autoimmunity: Diagnostic and therapeutic considerations exemplified by 3 anti-Ro/SSA-associated cases 141
Peripheral lymphocyte subset monitoring in COVID19 patients: a prospective Italian real-life case series 138
Prolongation of the corrected QT interval in adult patients with anti-Ro/SSA positive connective tissue diseases. 137
Isolated atrioventricular block of unknown origin in adults and anti-Ro/SSA antibodies: Clinical evidence, putative mechanisms, and therapeutic implications 137
Assessing QT interval in patients with autoimmune chronic inflammatory diseases: perils and pitfalls 134
Pravastatin treatment-associated reduction in plasma homocysteine in heart-transplanted patients. 133
Early and delayed increase in plasma homocysteine levels in heart transplanted patients. 132
Using peripheral blood mononuclear cells to determine proteome profiles in human cardiac failure. 131
Rosuvastatin inhibits spontaneous and IL-1β-induced interleukin-6 production from human cultured osteoblastic cells. 131
Pharmacokinetics and pharmacodynamics of neutrophil-associated ciprofloxacin in humans. 130
Joint use of cardio-embolic and bleeding risk scores in elderly patients with atrial fibrillation 130
Simvastatin inhibits T cell activation by selectively impairing the function of RAS superfamily GTPases. 129
The role of P2X7 receptors in tissue fibrosis: a brief review 129
Changes of peripheral A2A adenosine receptors in chronic heart failure and cardiac transplantation. 128
Biologic drugs and arrhythmic risk in chronic inflammatory arthritis: the good and the bad 128
Cyclosporin and tacrolimus increase plasma levels of adenosine in kidney transplanted patients 128
Systemic inflammation and arrhythmic risk: lessons from rheumatoid arthritis 127
null 126
Autoimmune and inflammatory K+ channelopathies in cardiac arrhythmias: Clinical evidence and molecular mechanisms 126
Comparison of disease clusters in two elderly populations hospitalized in 2008 and 2010 125
The "Invulnerability" of the Adult Conduction System to Anti-Ro/SSA Antibodies? A Matter of Calcium Channel Expression on the Cardiomyocyte 125
Comparison of frequency of complex ventricular arrhythmias in patients with positive versus negative anti-Ro/SSA and connective tissue disease 124
Gout, allopurinol intake and clinical outcomes in the hospitalized multimorbid elderly 123
Autoimmune channelopathies as a novel mechanism in cardiac arrhythmias 123
null 122
null 122
Ultrasound measurement of rectus femoris muscle thickness as a quick screening test for sarcopenia assessment 122
Idiopathic recurrent pericarditis refractory to colchicine treatment can reveal tumor necrosis factor receptor-associated periodic syndrome 120
null 120
Heart failure and chronic kidney disease in a registry of internal medicine wards 117
Allopurinol prevents ischaemia-dependent haemorheological changes 117
Homocysteine and Raynaud’s phenomenon: a review. 117
Multimorbidity and polypharmacy in the elderly: Lessons from REPOSI 116
Development and preliminary validation of a diagnostic score for identifying patients affected with adult-onset autoinflammatory disorders. 116
The effects of age and hyperhomocysteinemia on the redox forms of plasma thiols 115
Reduction in plasma homocysteine level in patients with rheumatoid arthritis given pulsed glucocorticoid treatment. 114
Familial Mediterranean fever diagnosed in an elderly patient 113
Prophylaxis of venous thromboembolism in elderly patients with multimorbidity 113
Inflammatory cytokines, life-threatening arrhythmias and premature mortality in chronic inflammatory arthritis: Time to focus on 113
null 113
Statins as a new therapeutic perspective in myocarditis and postmyocarditis dilated cardiomyopathy 111
Arrhythmic risk in rheumatoid arthritis: the driving role of systemic inflammation. 111
Combination Therapy With Ceftriaxone and Lansoprazole, Acquired Long QT Syndrome, and Torsades de Pointes Risk 110
Potassium Channel Block and Novel Autoimmune-Associated Long QT Syndrome 109
Autoimmune Calcium Channelopathies and Cardiac Electrical Abnormalities 109
Autoantibody-mediated cardiac arrhythmias: mechanisms and clinical implications 108
Cardioimmunology of arrhythmias: the role of autoimmune and inflammatory cardiac channelopathies 108
Cardiac dysautonomia in patients with superior vena cava syndrome due to compression by lung cancer. 107
Comment on: Letter to the Editor from Clockaerts and Bierma-Zeinstra. 107
null 105
Emerging arrhythmic risk of autoimmune and inflammatory cardiac channelopathies 105
Acute effects of glibenclamide on reactive hyperaemia in the lower limbs in humans. 103
Cannabinoids inhibit fibrogenesis in diffuse systemic sclerosis fibroblasts. 103
One dose of an MF59-adjuvanted pandemic A/H1N1 vaccine recruits pre-existing immune memory and induces the rapid rise of neutralizing antibodies 103
Long QT Syndrome: An Emerging Role for Inflammation and Immunity 101
Human rheumatoid synoviocytes express functional P2X7 receptors 100
Oral low-dose dipyridamole protects from intravenous high-dose dipyridamole-induced ischemia. A oral echocardiographic study 99
Pathogenesis of the novel autoimmune-associated long-QT syndrome 99
Priming for Pandemic Influenza: Antigen-sparing MF59™-adjuvanted A/H5N1 Vaccine Induces Immunological Memory and Shows Cross-Reactive Potential in Adults Including the Elderly 99
Photopheresis immunomodulation after heart transplantation. 97
Inhibition of microsomal glucose-6-phosphate transport in human neutrophils results in apoptosis: a potential explanation for neutrophil dysfunction in glycogen storage disease type 1b 97
Zygomycosis in Italy: a survey of FIMUA-ECMM (Federazione Italiana di Micopatologia Umana ed Animale and European Confederation of Medical Mycology). 97
Surveillance for severe acute respiratory infections among hospitalized subjects from 2015/2016 to 2019/2020 seasons in tuscany, Italy 97
Homocysteine and P wave dispersion in patients with heart transplantation 96
Simvastatin reduces MMP-3 level in interleukin 1b-stimulated human chondrocyte culture. 96
Anti-Ro/SSA antibodies and cardiac arrhythmias in the adult: facts and hypotheses 95
Primary subcutaneous zygomycosis due to Rhizopus oryzae in a 71-year-old man with normal immune status. 93
Using Peripheral Blood Mononuclear Cells to determine proteome profiles in human end-stage chronic heart disease 93
Systemic adenosine increase during cold pressor test is dependent on sympathetic activation. 90
Hyperhomocysteinemia: a cardiovascular risk factor in autoimmunediseases? 90
Simvastatin inhibits cytokine production and nuclear factor-kB activation in interleukin 1beta-stimulated synoviocytes from rheumatoid arthritis patients 89
Interleukin-6 inhibition of hERG underlies risk for acquired long QT in cardiac and systemic inflammation 89
Totale 13055
Salva come PNG Salva come JPEG
Categoria #
all - tutte 29005
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29005
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/201828 0000 00 00 00028
2018/20192331 181019537 36353 222124 86305492453
2019/20203795 418134227543 230356 423476 313331124220
2020/20213099 13925994361 175350 206367 325284261278
2021/20222234 159287137172 16279 13299 139200226442
2022/20232617 165261377383 208510 84204 27964820
Totale 15431